What do drug monopolies cost consumers in developing countries?

Rebecca Hellerstein

Economics Letters, 2012, vol. 116, issue 1, 108-111

Abstract: This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

Keywords: Intellectual property rights; International price discrimination; TRIPS agreement; Pharmaceutical industry; Markups (search for similar items in EconPapers)
JEL-codes: D4 F13 L1 L65 O34 (search for similar items in EconPapers)
Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0165176511006379
Full text for ScienceDirect subscribers only

Related works:
Working Paper: What do drug monopolies cost consumers in developing countries? (2011)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:ecolet:v:116:y:2012:i:1:p:108-111

DOI: 10.1016/j.econlet.2011.12.114

Access Statistics for this article

Economics Letters is currently edited by Economics Letters Editorial Office

More articles in Economics Letters from Elsevier
Bibliographic data for series maintained by Catherine Liu ().